Literature DB >> 9228034

Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding.

D C Mynarcik1, P F Williams, L Schaffer, G Q Yu, J Whittaker.   

Abstract

Insulin and insulin-like growth factor 1 (IGF-1) are peptides that share nearly 50% sequence homology. However, although their cognate receptors also exhibit significant overall sequence homology, the affinity of each peptide for the non-cognate receptor is 2-3 orders of magnitude lower than for the cognate receptor. The molecular basis for this discrimination is unclear, as are the molecular mechanisms underlying ligand binding. We have recently identified a major ligand binding site of the insulin receptor by alanine scannning mutagenesis. These studies revealed that a number of amino acids critical for insulin binding are conserved in the IGF-1 receptor, suggesting that they may play a role in ligand binding. We therefore performed alanine mutagenesis of these amino acids to determine whether this is the case. cDNAs encoding alanine-substituted secreted recombinant IGF-1 receptors were expressed in 293 EBNA cells, and the ligand binding properties of the expressed proteins were evaluated. Mutation of Phe701 resulted in a receptor with undetectable IGF-1 binding; alanine substitution of the corresponding amino acid of the insulin receptor, Phe714, produces a 140-fold reduction in affinity for insulin. Mutation of Asp8, Asn11, Phe58, Phe692, Glu693, His697, and Asn698 produces a 3.5-6-fold reduction in affinity for IGF-1. In contrast, alanine mutation of the corresponding amino acids of the insulin receptor with the exception of Asp12 produces reductions in affinity that are 50-fold or greater. The affinity of insulin for these mutants relative to wild type receptor was similar to that of their relative affinity for IGF-1 with two exceptions; the IC50 values for insulin binding to the mutants of Arg10, which has normal affinity for IGF-1, and His697, which has a 6-fold reduction in affinity for IGF-1, were both at least 2 orders of magnitude greater than for wild type receptor. The Kd values for insulin of the corresponding alanine mutants of the insulin receptor, Arg14 and His710, are 2-3 orders of magnitude greater than for wild type receptor. However, in contrast, the relative affinity of des(25-30)[PheB25 alpha-carboxamide]insulin for these IGF-1 receptor mutants is reduced only 4- and 50-fold, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228034     DOI: 10.1074/jbc.272.30.18650

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Biochemical and physiological properties of a novel series of long-acting insulin analogs obtained by acylation with cholic acid derivatives.

Authors:  Ib Jonassen; Svend Havelund; Ulla Ribel; Anne Plum; Mette Loftager; Thomas Hoeg-Jensen; Aage Volund; Jan Markussen
Journal:  Pharm Res       Date:  2006-12-21       Impact factor: 4.200

2.  The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity.

Authors:  Meizhen Lou; Thomas P J Garrett; Neil M McKern; Peter A Hoyne; V Chandana Epa; John D Bentley; George O Lovrecz; Leah J Cosgrove; Maurice J Frenkel; Colin W Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

3.  IGF1R variants associated with isolated single suture craniosynostosis.

Authors:  Michael L Cunningham; Jeremy A Horst; Mark J Rieder; Anne V Hing; Ian B Stanaway; Sarah S Park; Ram Samudrala; Matthew L Speltz
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

4.  Extending Halogen-based Medicinal Chemistry to Proteins: IODO-INSULIN AS A CASE STUDY.

Authors:  Krystel El Hage; Vijay Pandyarajan; Nelson B Phillips; Brian J Smith; John G Menting; Jonathan Whittaker; Michael C Lawrence; Markus Meuwly; Michael A Weiss
Journal:  J Biol Chem       Date:  2016-11-14       Impact factor: 5.157

Review 5.  The three dimensional structure of the type I insulin-like growth factor receptor.

Authors:  C W Ward; T P Garrett; N M McKern; M Lou; L J Cosgrove; L G Sparrow; M J Frenkel; P A Hoyne; T C Elleman; T E Adams; G O Lovrecz; L J Lawrence; P A Tulloch
Journal:  Mol Pathol       Date:  2001-06

6.  Precise mapping of an IGF-I-binding site on the IGF-1R.

Authors:  Mehrnaz Keyhanfar; Grant W Booker; Jonathan Whittaker; John C Wallace; Briony E Forbes
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

7.  Crystallization of the first three domains of the human insulin-like growth factor-1 receptor.

Authors:  N M McKern; M Lou; M J Frenkel; A Verkuylen; J D Bentley; G O Lovrecz; N Ivancic; T C Elleman; T P Garrett; L J Cosgrove; C W Ward
Journal:  Protein Sci       Date:  1997-12       Impact factor: 6.725

8.  Are all regions of folded proteins that undergo ligand-dependent order-disorder transitions targets for allosteric peptide mimetics?

Authors:  Aron W Fenton
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

9.  A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II.

Authors:  Clair L Alvino; Kerrie A McNeil; Shee Chee Ong; Carlie Delaine; Grant W Booker; John C Wallace; Jonathan Whittaker; Briony E Forbes
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

10.  Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I.

Authors:  Lisbeth Gauguin; Carlie Delaine; Clair L Alvino; Kerrie A McNeil; John C Wallace; Briony E Forbes; Pierre De Meyts
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.